Summary of Classification and Labelling
Notified classification and labelling
General Information
|
N-((1r,4r)-4-(3-halo-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxopiperidin-3-yl)-6-halo-1,3-dioxoisoindolin-5-yl)piperazin-1-yl)methyl)piperidin-1-yl) heteropolycycle |
|
Notified classification and labelling according to CLP criteria
Repr. 2 |
H361
(H361fd - Suspec...)
|
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
|
|
H361fd
|
STOT RE 2 |
H373
(liver)
(oral)
|
H373
(affected organ:...)
|
Number of Aggregated Notifications: 1